Pure Global
NCT03804918

Mobile Learning to Improve Clinician's Ability to Break Bad News

Mobile Learning Resources as a Tool for Improving Clinician's Ability to Break Bad News: A Pre-post Mixed Methods Pilot Study
Imperial College London·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Education
Drug/Device/Intervention
VitalTips mobile application
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Imperial College London
Location
London,London,London, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Feb 25, 2019
End date
Aug 30, 2019
Enrollment
17 participants
Primary outcome

Change in Self-assessed Likert Scale Relating to Confidence in Breaking Bad News at Baseline and Post-intervention.,Change in Simulated Patient Encounter Marking Scores Related to Breaking Bad News at Baseline and Post-intervention.

Summary

Design:
 
 A pre-post mixed methods pilot study. All participants granted access to a breaking bad news
 mobile learning resource (VitalTips).
 
 Baseline and post-intervention questionnaires, pre- and post-intervention simulated patient
 encounters, and post-intervention semi-structured interviews.
 
 Objective:
 
 To assess if a selected breaking bad news mobile learning resource can improve the ability of
 clinicians to break bad news.
 
 Population/Eligibility:
 
 15-20 junior doctors and nurses working within two NHS hospitals trusts and one private
 hospital in England.
 
 Duration:
 
 25th February 2019 to 8th July 2019.

ICD-10 classifications
Underachievement in schoolInstitutional upbringingProblem related to education and literacy, unspecifiedOther problems related to education and literacyProblems related to education and literacy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03804918
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03804918 through Pure Global AI's free database. This phase not specified trial is sponsored by Imperial College London and is currently Completed. The study focuses on Education. Target enrollment is 17 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.